In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

International Journal of Pharmaceutics

Volumn 458, Issue 1, 2013, Pages 83-89

  Rivera Rodriguez, Gustavo R ^a,b,f   Lollo, Giovanna ^a,b,c   Montier, Tristan ^c,d   Benoit, Jean Pierre ^d,e   Passirani, Catherine ^d,e   Alonso, Maria José ^a,b   Torres, Dolores ^b  

^a Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITÉ D'ANGERS   (France)

^d INSERM   (France)

^e UNIVERSITÉ D'ANGERS   (France)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cancer therapy; Docetaxel; Nanocapsules; Poly l asparagine; Polyaminoacids; Tumor targeting

Indexed keywords

ASPARAGINE; DOCETAXEL; MIGLYOL; NANOCAPSULE; POLOXAMER; POLY L ASPARAGINE NANOCAPSULE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SIZE; CIRCULATION TIME; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SCREENING; FEMALE; GLIOMA; HEMOLYSIS; IN VIVO STUDY; MEAN RESIDENCE TIME; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SURVIVAL TIME; ZETA POTENTIAL;

CANCER THERAPY; DOCETAXEL; NANOCAPSULES; POLY-L-ASPARAGINE; POLYAMINOACIDS; TUMOR TARGETING;

ANIMALS; ANTINEOPLASTIC AGENTS; ASPARAGINE; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLIOMA; MICE; NANOCAPSULES; PARTICLE SIZE; TAXOIDS; TISSUE DISTRIBUTION;

EID: 84888314452     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.09.038     Document Type: Article

References (29)

1. J.D. Allan, J.T. Ireland, J. Milner, and A.D. Moss l-Asparagine, l-asparaginase and cancer Lancet 1 1967 682 686
2. E. Allard, N.T. Huynh, A. Vessieres, P. Pigeon, G. Jaouen, J.P. Benoit, and C. Passirani Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model Int. J. Pharm. 379 2009 317 323
3. M.J. Alonso, and P. Couvreur Historical view of the design and development of nanocarriers for overcoming biological barriers Nanostructured Biomaterials for Overcoming Biological Barriers 2012 The Royal Society of Chemistry 3 36 (Chapter 1)
4. P. Calvo, J.L. Vila-Jato, and M.J. Alonso Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers Int. J. Pharm. 153 1997 41 50 (Pubitemid 27283332)
5. B. Chabner, and A. Friedmann Asparaginase B. Chabner, D. Longo, Cancer Chemotherapy and Biotherapy: Principles and Practice 2006 Lippincott Williams & Wilkins Philadelphia 879
6. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes J. Control. Release 63 2000 19 30 (Pubitemid 30046939)
7. F. Danhier, N. Lecouturier, B. Vroman, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
8. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 2006 1710 1722 (Pubitemid 44323239)
9. P. Hervella, V. Lozano, M. Garcia-Fuentes, and M.J. Alonso Nanomedicine: new challenges, opportunities in cancer therapy J. Biomed. Nanotechnol. 4 2008 276 292
10. N.T. Huynh, E. Roger, N. Lautram, J.P. Benoit, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine 5 2010 1415 1433
11. S.H. Lee, S.D. Yoo, and K.H. Lee Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 724 1999 357 363 (Pubitemid 29148097)
12. Y. Li, J. Wang, M.G. Wientjes, and J.L. Au Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor Adv. Drug Deliv. Rev. 64 2012 29 39
13. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, and Z. Zhang Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Deliv. Rev. 60 2008 1650 1662
14. M.V. Lozano, D. Torrecilla, D. Torres, A. Vidal, F. Dominguez, and M.J. Alonso Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers Biomacromolecules 9 2008 2186 2193
15. K.B. McCredie, D.H.W. Ho, and E.J. Freireich l-Asparaginase for the treatment of cancer CA Cancer J. Clin. 23 1973 220 227
16. J.M. Metselaar, P. Bruin, L.W.T. De Boer, T. De Vringer, C. Snel, C. Oussoren, M.H.M. Wauben, D.J.A. Crommelin, G. Storm, and W.E. Hennink A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity Bioconjug. Chem. 14 2003 1156 1164 (Pubitemid 37449043)
17. A.O. Nornoo, D.W. Osborne, and D.S.L. Chow Cremophor-free intravenous microemulsions for paclitaxel: I: Formulation, cytotoxicity and hemolysis Int. J. Pharm. 349 2008 108 116 (Pubitemid 350299695)
18. F.A. Oyarzun-Ampuero, G.R. Rivera-Rodríguez, M.J. Alonso, and D. Torres Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery Eur. J. Pharm. Sci. 2013 483 490
19. G.R. Rivera-Rodriguez, M.J. Alonso, and D. Torres Poly-l-asparagine nanocapsules as anticancer drug delivery vehicles Eur. J. Pharm. Biopharm. 2013 (in press)
20. B. Romberg, J.J. Kettenes-Van Den Bosch, T. De Vringer, G. Storm, and W.E. Hennink 1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl-l-asparagine)-coated liposomes Bioconjug. Chem. 17 2006 860 864 (Pubitemid 43794399)
21. B. Romberg, J.M. Metselaar, L. Baranyi, C.J. Snel, R. Bünger, W.E. Hennink, J. Szebeni, and G. Storm Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes Int. J. Pharm. 331 2007 186 189 (Pubitemid 46223617)
22. B. Romberg, C. Oussoren, C.J. Snel, W.E. Hennink, and G. Storm Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s Pharm. Res. 24 2007 2394 2401 (Pubitemid 350060711)
23. B. Romberg, C. Oussoren, C.J. Snel, M.G. Carstens, W.E. Hennink, and G. Storm Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration Biochim. Biophys. Acta 1768 2007 737 743 (Pubitemid 46275604)
24. M. Senthilkumar, P. Mishra, and N.K. Jain Long circulating PEGylated poly(d,l-lactide-co-glycolide) nanoparticulate delivery of docetaxel to solid tumors J. Drug Target. 16 2008 424 435 (Pubitemid 351935740)
25. N. Verma, K. Kumar, G. Kaur, and S. Anand l-Asparaginase: a promising chemotherapeutic agent Crit. Rev. Biotechnol. 27 2007 45 62 (Pubitemid 46425934)
26. S. Wadhwa, A. Jain, J.G. Woodward, and R.J. Mumper Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses Eur. J. Pharm. Biopharm. 80 2012 315 322
27. A.Z. Wang, R. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 63 2012 185 198
28. T. Yang, F.-D. Cui, M.-K. Choi, J.-W. Cho, S.-J. Chung, C.-K. Shim, and D.-D. Kim Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation Int. J. Pharm. 338 2007 317 326 (Pubitemid 46777245)
29. M.K. Yu, J. Park, and S. Jon Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy Theranostics 2 2012 3 44